This development plays into broader trends toward more protein, but crucially, it targets the growing number of GLP-1 users, as lowsugar protein sodas reduce glycemic spikes and align with their need for more nutrition from a smaller intake
medication pricing system, which allows manufacturers to set higher list prices
Author: SNS Insider, Matthew Benjamin, Kinjel Shah, and Abigail Beaney
These conditions can be life-threatening
Patients were randomized 1:1 to receive subcutaneous semaglutide 2.4 mg once weekly or placebo as an adjunct to standard-of-care therapy for CVD, such as cholesterol-modifying medications, antiplatelet therapies and antihypertensive agents
Rubbing spreads blood under the skin and increases bruising